• Department of Hematology; Hua shan Hospital and Clinical Epidemiology/Evidenced-Based Medicine Center; Fudan University; Shanghai 200040; China;
Export PDF Favorites Scan Get Citation

To identify the best evidence in the management of indicator, short and long term of prophylactic platelet transfusion in patient with myelodysplastic syndrome (MDS). We searched the latest evidence-based guidelines in PubMed,reviewed and appraised these guidelines. Clinical decision was made based on the guidelines and the actual patient with MDS. Perfect treatment effect was obtained through evidence-based clinical decision.

Citation: WANG Xiaoqin. Using Evidence-Based Guideline for Prophylactic Platelet Transfusion in Patient with Myelodysplastic Syndrome. Chinese Journal of Evidence-Based Medicine, 2005, 05(6): 482-484. doi: Copy